Solve challenges in your cell therapy manufacturing with support from our PD teams. We can help you optimize a single unit operation or design a start-to-finish process that scales from clinical trials to commercialization.
Specialties include expansion and characterization of CAR T and other T cell types, NK cells, PSC, and MSC plus associated viral vectors for gene-delivered therapies (i.e., adeno-associated virus and lentivirus).
Media and assay development
Achieve a robust cell therapy manufacturing process by optimizing the media early in your process. Work with us to develop media for your cells’ specific needs.
Integrated and automated media development and optimization, tissue culture, and analytics allow screening of up to 10 000 formulations at once. Equipment works for different cell types and across many workflows: activation, isolation, differentiation, transduction, induction, expansion.
Contract manufacturing services
Use our GMP manufacturing facilities to support clinical trials while building your internal production capabilities. Our CMO teams provide transparency into manufacturing protocols and also support technology transfer to your facility or CMOs.
Designed for compliance with Canadian, US, and EU cGMP; ISO certification; new ATMP Guidelines (Toronto).
Toronto: Phase 1 and 2 batches for CAR T, PSC, MSC, viral vector
Shanghai: Pilot batches for plasmid, LVV, AAV, CAR T
Cell and gene therapy talent is in short supply. Train your existing team and standardize their manufacturing techniques. Our 3-day CELLT1 course combines theory and lab work on end-to-end GMP manufacturing.
Learn from our experienced trainers and other attendees in this interactive course. Held in: Shanghai, China; Songdo, Korea; Marlborough, USA; and Uppsala, Sweden.